Q32 Bio QTTB
NASDAQ QTTB
$8.67 +0.05 (+0.58%)
At close: Oct 21, 2026 · 4:00 PM EDT

Q32 Bio (QTTB) Convertible Debt (2023)

Updated

Q32 Bio's Convertible Debt was $38.6 million in Q4 2023.

Analysis

Q32 Bio (QTTB) Convertible Debt (2023) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn
10 Q32 Bio 176.77 Mn -97.52 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2023 38.60 Mn
API Access

Q32 Bio Convertible Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=convertible-debt&ticker=QTTB&period=max&api_key=YOUR_API_KEY